Home 2019 International Forum on Medical Science and Technology Innovation Leadership

2019 International Forum on Medical Science and Technology Innovation Leadership

Mar 07, 2019 16:37 CST Updated 16:37
Medlinker

Chronic Disease Management Platform Provider

To further promote innovation and creativity in China’s healthcare sector, showcase to the world the remarkable achievements of China’s healthcare reform and innovation, and foster exchange and interaction among leading figures in medical innovation from China and abroad, the “2019 International Forum on Leadership in Medical Science and Technology Innovation” (hereinafter referred to as “the Forum”) will be held in Chengdu, Sichuan Province, on May 11–12, 2019. The Forum is jointly hosted by the Chinese Academy of Medical Sciences & Peking Union Medical College and the Journal of the American Medical Association (JAMA), and co-organized by the Training Center of Peking Union Medical College, the International Medical Services and Management Professional Committee of the Chinese Hospital Association, and Medlinker.


医联2.png 
This forum is a premier medical extravaganza, featuring a main forum alongside sub-forums dedicated to the healthcare industry and scientific research. Additionally, more than ten specialized sub-forums are planned, covering disciplines such as rare diseases, infectious diseases, nephrology, endocrinology, anticoagulation, gynecologic oncology, women’s health, cardiology, critical care respiratory medicine, oncology, ophthalmology, and transplantation. The organizer, the Chinese Academy of Medical Sciences (CAMS), is China’s only national-level academic center for medical sciences and comprehensive medical research institution, operating in integration with Peking Union Medical College. The Journal of the American Medical Association (JAMA) is one of the four top-tier international medical journals, ranking third in terms of SCI impact factor.


At that time, Zhang Shuyang, Vice President of the Chinese Academy of Medical Sciences & Peking Union Medical College and Vice President of Peking Union Medical College Hospital; Zheng Zhongwei, Vice President of the Chinese Academy of Medical Sciences & Peking Union Medical College; Howard Bauchner, Senior Vice President of the American Medical Association (AMA) and Editor-in-Chief of the Journal of the American Medical Association (JAMA); Anne Rentoumis Cappola, Deputy Editor of JAMA and Senior Physician at the Hospital of the University of Pennsylvania; Deborah Schrag, Deputy Editor of JAMA and Professor of Medicine at Harvard Medical School; and many other distinguished medical experts from home and abroad will gather in Chengdu to discuss the latest academic frontiers.


In recent years, “innovation” has permeated the entire healthcare industry. Innovations in national policies on internet-based healthcare, the structure of the healthcare industry, business models for internet-based healthcare, drug research and development and promotion, and talent cultivation models, coupled with continuous advancements in medical science and technology, have infused the entire healthcare sector with vibrant vitality and transformative energy.


Medical innovation is inseparable from industrial innovation. Notably, the Healthcare Industry Sub-forum of this year’s conference, held in conjunction with the 2nd Medlink Summit, has invited Wang Haitao, Dean of the School of Continuing Education at Peking Union Medical College; Wang Shirui, Founder and CEO of Medlinker and CEO of Penguin Almond; as well as representatives from leading enterprises across various sectors and officials from relevant local regulatory authorities. They will engage in discussions on key topics such as pharmaceutical policies, innovation and entrepreneurship in the healthcare and pharmaceutical industries, cultivation of innovative medical talent, and the new ecosystem of smart city healthcare, jointly assessing policy trends and industry dynamics.


The 2019 International Medical Technology Innovation Leadership Forum has officially launched.